Get the Stockscreener App
5.14
7.05%
-0.39
After Hours:
5.14
Avita Medical Inc stock is traded at $5.14, with a volume of 274.25K.
It is down -7.05% in the last 24 hours and up +23.26% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$5.53
Open:
$5.51
24h Volume:
274.25K
Relative Volume:
0.44
Market Cap:
$136.82M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-3.6714
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
-7.22%
1M Performance:
+23.26%
6M Performance:
-40.44%
1Y Performance:
-48.03%
1-Day Range:
$5.02
$5.51
1-Week Range:
$5.02
$5.615
52-Week Range:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.14 | 149.41M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical Inc. stock trend forecastSell Signal & High Win Rate Trade Tips - newser.com
Real time social sentiment graph for AVITA Medical Inc.July 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Why AVITA Medical Inc. stock remains resilient2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Using economic indicators to assess AVITA Medical Inc. potentialBond Market & Short-Term Trading Opportunity Alerts - newser.com
What technical models suggest about AVITA Medical Inc.’s comebackMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Smart tools for monitoring AVITA Medical Inc.’s price actionJuly 2025 Update & Technical Pattern Alert System - newser.com
Applying sector rotation models to AVITA Medical Inc.2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
Will AVITA Medical Inc. stock recover faster than peers2025 Market WrapUp & Long-Term Capital Growth Strategies - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Avita Medical (NASDAQ:RCEL) - MarketBeat
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA - GlobeNewswire
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders - GlobeNewswire Inc.
How to interpret RSI for AVITA Medical Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Custom strategy builders for tracking AVITA Medical Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
What drives AVITA Medical Inc stock priceStraddle and Strangle Trades & Bull Bear Market Updates - earlytimes.in
Understanding AVITA Medical Inc.’s price movementJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc.RCEL - Eastern Progress
RCEL: Kirby McInerney LLP Continues Securities Investigation on Behalf of AVITA Medical, Inc. Investors - ACCESS Newswire
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Upcoming Events - FinancialContent
AVITA Medical, Inc. (NASDAQ:RCEL) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Combining machine learning predictions for AVITA Medical Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com
Applying Wyckoff theory to AVITA Medical Inc. stock2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Avita Medical's RECELL System Secures CMS Reimbursement for Acute Wound Care - MarketScreener
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds - Investing News Network
AVITA Medical (RCEL) Secures NTAP Reimbursement for RECELL - GuruFocus
$4,875 Per Treatment: AVITA Medical's RECELL System Gets Major Medicare Reimbursement Boost for Wound Care - Stock Titan
Securities Fraud Investigation Into AVITA Medical, Inc. - GlobeNewswire
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire
What to expect from AVITA Medical Inc. in the next 30 daysJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Market reaction to AVITA Medical Inc.’s recent news2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
What analysts say about Melco International Development Limited MX7A stockSector Rotation Strategies & Free Risk Assessment and Control - earlytimes.in
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Hold" by Analysts - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL): Is Breakeven Near? - 富途牛牛
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. - Bluefield Daily Telegraph
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm | Dow Theory Letters - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical - Bluefield Daily Telegraph
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):